A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.

At every level of leadership, Premier’s experts are driving healthcare forward.

Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.  

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.  

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Data, inquiry and intervention services.

Our most recent insights, articles and more, all in one place.  

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

Compelling stories from the front lines of America’s health systems.

Hospitals and Health Systems Stock up on Pandemic Medications for Potential Second Wave

Published in: HealthLeaders Media

According to a new survey from Premier Inc., 88% of the company's member hospitals and health systems are "building up safety stocks" of medications to prepare for another coronavirus patient surge.

The survey was conducted from June 11 to 29 and surveyed almost 90 health systems in the United States.

Fifty-one percent said they are building at least a one-month supply, while 25% of members say they are planning to stock up with a two-month supply.

The following drug classes used to treat COVID-19 were cited as part of the drug supply stocks:

  • 92% said they will stock sedatives such as midazolam and propofol
  • 91% said they will stock neuromuscular blockers such as cisatracurium and vecuronium
  • 88% said they will stock controlled substances such as fentanyl and morphine
  • 81% said they will stock agents for rapid intubation such as rocuronium and succinylcloline
  • 75% said they will stock vasopressors such as norepinephrine and vasopressin
  • And 51% said they will stock up on induction agents such as etomidate

Full Story

Login Register Change Registration